T cell recognition of a point mutation in the P21 Ras protein

Leukemia. 1993 Aug:7 Suppl 2:S27-30.

Abstract

Point mutations of p21 Ras proteins correlate with many human malignancies. To determine whether the mutations of Ras proteins generate immunogenic determinants which can be recognized by T cells and possibly serve as targets for immunotherapy, we studied the murine T helper responses to synthetic Ras peptides corresponding to amino acids 1-23 of normal or mutant Ras protein. Immunization of C3H/He and B10.BR mice with Ras peptides containing a valine mutation at position 12 stimulated MHC class II-restricted T helper cells which recognised specifically the Ras mutation. Surprisingly C57BL/10 mice generated T helper responses not only against mutant but also against normal Ras peptides. Importantly, natural processing of Ras protein was found to generate the epitopes recognized by the peptide-induced T cells.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Epitopes / immunology*
  • Immunization
  • Immunotherapy
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Oncogene Protein p21(ras) / administration & dosage
  • Oncogene Protein p21(ras) / genetics
  • Oncogene Protein p21(ras) / immunology*
  • Point Mutation / genetics
  • Point Mutation / immunology*
  • Species Specificity
  • T-Lymphocytes / immunology*

Substances

  • Epitopes
  • Oncogene Protein p21(ras)